ALBERT DAVID LIMITED
ALBERTDAVD · General/Diversified · NSE
₹697
Current Market Price
Fair Value (DCF)
₹200
Margin of Safety
-71.3%
Updated 1d ago
YieldIQ Score
12/100
Piotroski F-Score
3/9
Economic Moat
None
Confidence
57%
ROE
—
Debt/Equity
0.11
WACC
11.1%
Market Cap
₹398 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
6.3%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
85.1×
EBIT covers interest
Current Ratio
3.40×
Short-term liquidity
Asset Turnover
0.67×
Revenue per ₹ of assets
Revenue CAGR (3Y)
3.2%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹697.3
Bear case
₹123.89
MoS -462.8%
Base case
₹199.84
MoS -248.9%
Bull case
₹294.31
MoS -136.9%
Ratio Trends
ALBERTDAVD · last 9 annual periods
ROE
4.4%
ROCE
8.0%
Operating Margin
—
Debt / Equity
0.03×
PE
78.3×
EV / EBITDA
5.0×
Historical Financials
ALBERTDAVD · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹247 Cr | ₹314 Cr | ₹342 Cr | ₹362 Cr | ₹343 Cr | +8.5% |
| EBITDA | — | ₹56.5 Cr | ₹59.6 Cr | ₹104 Cr | ₹32.5 Cr | -12.9% |
| EBIT | ₹28.1 Cr | ₹47.8 Cr | ₹51.2 Cr | ₹97.6 Cr | — | +36.5% |
| PAT | ₹22.1 Cr | ₹35.3 Cr | ₹36.2 Cr | ₹75.4 Cr | ₹17.2 Cr | -6.1% |
| EPS (diluted) | ₹38.80 | ₹61.78 | ₹63.39 | ₹132.15 | — | +35.8% |
| CFO | ₹36.6 Cr | ₹40.4 Cr | ₹10.5 Cr | ₹45.5 Cr | ₹-28.4 Cr | — |
| CapEx | — | — | — | — | ₹-14.9 Cr | — |
| FCF | — | — | — | — | ₹-43.3 Cr | — |
| Total Assets | — | ₹401 Cr | ₹423 Cr | ₹498 Cr | ₹511 Cr | +6.3% |
| Total Debt | — | — | ₹4.7 Cr | ₹2.1 Cr | ₹12.3 Cr | +27.3% |
| Shareholders' Equity | — | — | ₹312 Cr | ₹383 Cr | ₹392 Cr | +5.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ALBERTDAVD vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| ZIMLAB ZIM LABORATORIES LIMITED | -71.8% | 38 | Above Fair Value | 4.8% | — |
| VALIANTLAB VALIANTLAB | — | — | Pending | -0.9% | — |
| KILITCH KILITCH DRUGS INDIA LTD | +176.1% | 62 | Data Limited | 13.3% | — |
| MEDICAMEQ MEDICAMEQ | — | — | Pending | 3.3% | — |
| MEDICO MEDICO REMEDIES LIMITED | -51.5% | 42 | Above Fair Value | 16.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ALBERTDAVD in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ALBERTDAVD →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ALBERTDAVD →
Compare
Head-to-head with peers
Compare ALBERTDAVD side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ALBERTDAVDNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.